221 related articles for article (PubMed ID: 12887811)
1. [Clinical characteristics of non-steroidal anti-inflammatory drugs associated gastroduodenal ulcer bleeding].
Zhang L; Lu YM; Ding SG; Liao ZL
Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):258-60. PubMed ID: 12887811
[TBL] [Abstract][Full Text] [Related]
2. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for peptic ulcer bleeding].
Søberg T; Hofstad B; Sandvik L; Johansen M; Lygren I
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1135-9. PubMed ID: 20531499
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
[TBL] [Abstract][Full Text] [Related]
6. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
[TBL] [Abstract][Full Text] [Related]
7. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
9. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori.
Chason RD; Reisch JS; Rockey DC
Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
11. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
12. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
[TBL] [Abstract][Full Text] [Related]
13. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of serious complicated gastroduodenal ulcers in Japan.
Ishikawa S; Inaba T; Mizuno M; Miyake Y; Okada H; Ishikawa H; Hori K; Wato M; Kawai K; Yamamoto K
Hepatogastroenterology; 2012; 59(113):147-54. PubMed ID: 22251530
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study.
Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A
Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993
[TBL] [Abstract][Full Text] [Related]
18. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
19. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
